Comprehensive Intervention to Evaluate Outcomes AND Cost in Hospitalized Surgical Patients With Diabetes Mellitus (DM)



Status:Completed
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:February 2012
End Date:February 2015
Contact:Kyle Carbone
Email:kcarbone3@partners.org
Phone:617-732-8311

Use our guide to learn which trials are right for you!

Comprehensive Intervention to Evaluate Outcomes AND Cost in Hospitalized Surgical Patients With DM: COACH-DM

This study is being performed to evaluate whether a comprehensive discharge planning and
close follow up for one year can improve clinical outcomes and cut costs of care for
patients with poorly controlled diabetes. The study takes a high risk approach and is
focused on patients admitted to hospital for elective surgery with HbA1c >8%. Secondary
goals include improving teamwork and communication for clinicians within the team and
teaching nurse practitioners and physicians-in-training how to work effectively within
interdisciplinary teams. Investigators anticipate that the results of this project may lead
to the following benefits: 1) improved health outcomes for surgical patients with diabetes,
2) improved strategies for better communication within interdisciplinary health care teams,
and 3) decreased health care costs.

All patients who are planned for elective surgery at the hospital are seen in the
pre-operative center a few days before admission. The diabetes management team becomes
involved in care of patients with HbA1c >8.0% at this time. Once the patients are admitted
to the hospital, the diabetes management team continues to follow them until they are ready
for discharge. At the point of discharge, patients are randomized to one of two arms- the
usual care group and the expanded diabetes management service (eDMS). The eDMS group is
followed closely for 1 year after discharge by the investigators to make sure they receive
appropriate care for their diabetes.

Aims of this study are:

1. To evaluate whether patients that receive the eDMS have lower re-hospitalization rates
at 1 month compared to patients who receive the traditional (current) DMS.
Investigators hypothesize that the eDMS program will have lower re-hospitalization
rates at 1 month.

2. To evaluate whether patients that receive the eDMS have lower HbA1c levels at 1 year
compared with patients who receive the traditional DMS. Investigators hypothesize that
patients in the eDMS program will have lower HbA1c levels and improved diabetes-related
health outcomes after 1 year in the program.

Inclusion Criteria:

- elective surgery

- HbA1c >=8% within 3 months before surgery

- Age > 18 years

Exclusion Criteria:

- undergoing same day surgery without post-operative admission

- HbA1c < 8%

- individuals undergoing bariatric surgery

- individuals with metastatic cancer or short life expectancy
We found this trial at
1
site
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials